ABSTRACT The effect on mucin output of placing dilute serum from healthy donors in contact with the luminal surface of human airway has been studied. Bronchi were dissected from lungs removed at operation. Mucins, radiolabelled biosynthetically, were collected from the luminal aspect of the bronchi, which were mounted in Ussing chambers. Serum added to the luminal aspect of the tissue, at dilutions ranging from 1:100 to 1:10 of Krebs-Henseleit solution, consistently increased the output of radiolabelled mucins. The concentrations of serum tested in these experiments lie within the range commonly found in sputum coughed from the lungs of those with inflamed airways. Serum diluted to 1:2500, which is roughly the concentration found in the normal human airway, had little or no effect on bronchial secretion. Increased leakage of serum into the inflamed airways is suggested as one of the stimuli that increase bronchial secretion.
Alteration in the balance between the production of mucus and its clearance is important in the pathogenesis of respiratory disease. Where secretion outstrips clearance mucus will accumulate in the airway, narrow the lumen, and predispose to infection. In diseases where the airway mucosa becomes inflamed secretions often block air passages and this occurs in acute or chronic bronchitis,' asthma,2 and cystic fibrosis.3 In such diseases serum proteins, normally present in the airways only at low concentrations,4 leak into the lumen.5 Blood in the airway lumen causes mucus secretion in animals,6 and recent reports7 have suggested that dilute serum proteins cause secretion into the cat trachea. If the human respiratory tract behaves in the same way, serum proteins may be one of the stimulants that augment mucus output into the the diseased airway. We wished to determine whether human serum in contact with the luminal surface of the bronchus evokes secretion.
Methods
The experiments were performed by the method of Phipps et al.8 Bronchi free of tumour were dissected from lungs freshly removed at operation and immersed in oxygenated Krebs-Henseleit solution at 0°C for transport to the laboratory. There they were opened, pinned flat on a wax surface with luminal side uppermost, and then mounted between the two halves of an Ussing chamber. Krebs-Henseleit solution, gassed with 5% carbon dioxide in oxygen and warmed to 37°C, was circulated through both. half chambers. Four mCi of sodium 35S-sulphate was added to the submucosal aspect of the Ussing chamber at the beginning of the experiment to radiolabel the secretory glycoproteins synthesised in the bronchial wall. For the experiments on the effect of serum, 18 pieces of mainstem, lobar, or segmental bronchi from 11 patients were used. Serum, diluted as described below, was added to the luminal half chamber at intervals. In addition, 13 control studies were performed on bronchial tissues from nine patients, to define the pattern of output of radiolabelled macromolecules in the absence of any stimuli.
At 15 minute intervals liquid was drained from the luminal side of the chamber, which was then refilled with 15 ml Krebs-Henseleit solution. In experiments in which serum had been given, the fluid collected was dialysed exhaustively against 0-15 mol/l sodium chloride (to prevent the precipitation of serum proteins) containing 0O01% (w/v) sodium azide and 0O01% sodium sulphate. In the control experiments the fluid collected was dialysed against distilled water, with the same additions. The Action of serum on the output of secretory glycoproteins from human bronchi in vitro final change of dialysis water contained 6 mol/l urea to dissolve insoluble mucus.
To In eight experiments the most concentrated serum (1: 10) was put in the luminal half chamber 2.5 hours after the start of the experiment. In six further experiments the effect of increasing concentrations of serum were investigated: 1:100 at 2.5 hours, 1:30 at 3-5 hours, and 1:10 at 4.5 hours. In a series of four experiments serum diluted 1:2500, about the concentration found in sputum from healthy lungs, was administered at 2-5 hours and then the 1:10 serum given at 3.5 hours.
The output of radioactivity after the addition of serum was calculated as the percentage Output of macromolecularly bound radioactivity during an experi)nent. Very dilute serum (1:2500) was added to the luminal halfof the Ussing Chamber at 2 5 hours and was followed by little change in the output ofbound radioactivity. The output ofbound radioactivity increased substantially after the addition ofserum at a dilution of 1:10. concentrations of serum (1:100, 1:30, and 1:10) were placed in the luminal half of the Ussing chambers at 2 5, 3.5, and 4*5 hours respectively. All concentrations increased the output of macromolecularly bound radiolabel, through the effects were not obviously dose related. The results are summarised in the table. The increases in output after exposure to serum are all significantly greater than those occurring at the same time in control experiments.
In a series of four experiments very dilute serum (1:2500) was added to the luminal half of the Ussing chamber after 2-5 hours and then serum diluted 1:10 was given at 3-5 hours (fig) . In these experiments the very dilute serum had little effect (median change +24-5%, range +1% to +46%: not significantly different from controls at 2-5 hours). Serum (1:10) at 3 5 hours again stimulated secretion (median change + 155 %, range + 63% to + 200%: p < 0.001 when this was compared with controls at 3*5 hours). In these four experiments the effect of the 1:10 serum at 3.5 hours was greater than that of the 1:2500 serum at 2-5 hours (p < 0.05).
Fractionation of material from the luminal chamber resulted in a single radiolabelled peak in the excluded volume of the Sepharose CL 2B column. No peak was found in the included volume.
Discussion
The presence of serum in the luminal half of the Ussing chamber increased the rate of release of radiolabelled macromolecules from the bronchi. 
